Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0

Glimsentro-PG1 Tablet SR

Prescription Icon
Prescription Required

Marketer

Sentro Pharma & Healthcare

Salt Composition

Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)

Overview Glimsentro-PG1 Tablet SR

Diabetic patients using Glycemia-Control SR tablets benefit from improved blood glucose management. This combined medication, used alongside a healthy diet and regular exercise, enhances insulin effectiveness in adult type 2 diabetics. Dosage and duration should strictly adhere to your physician's instructions; taking it with food mitigates potential stomach irritation. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dosage to prevent hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol consumption, or missed meals increases hypoglycemia risk; regular blood glucose monitoring is vital. Common side effects include nausea, diarrhea, abdominal discomfort, headache, potential bone fractures, and respiratory infections. Prior to commencing treatment, disclose any pre-existing kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require prior medical consultation. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption due to increased side effect potential.

Uses of Glimsentro-PG1 Tablet SR

Managing type 2 diabetes

Major Benefits of Glimsentro-PG1 Tablet SR:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimsentro-PG1 Tablet SR whole; do not crush, chew, or fracture it. Administer this medication with a meal.

Common Side effects of Glimsentro-PG1 Tablet SR:

  • Hypoglycemia (low blood glucose level)
  • Headache
  • Nausea
  • Diarrhea
  • Dizziness
  • Vomiting
  • Anemia (low number of red blood cells)
  • Weakness
  • Sinus infection

How to use Glimsentro-PG1 Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing it. It is recommended to take Glimsentro-PG1 Tablet SR with a meal.

How Glimsentro-PG1 Tablet SR works:

Glimsentro-PG1 SR tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct mechanisms to optimize blood sugar management when single or dual drug regimens prove inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further improves insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimsentro-PG1 Tablet SR and alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimsentro-PG1 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against these risks prior to prescription. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Prolonged-release Glimsentro-PG1 tablets should likely be avoided while breastfeeding. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimsentro-PG1 Tablet SR cautiously, potentially requiring dose modification. Severe kidney disease contraindicates its use. Physician consultation is essential. Regular kidney function monitoring is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimsentro-PG1 Tablet SR cautiously, potentially requiring a modified dosage. Consult a physician before use. Glimsentro-PG1 Tablet SR is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Glimsentro-PG1 Tablet SR :

Should you forget a Glimsentro-PG1 Tablet SR dose, take it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Never take a double dose.

Facts to Know About Glimsentro-PG1 Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimsentro-PG1 Tablet SR

Consuming alcohol while taking Glimsentro-PG1 Tablet SR is unsafe. Alcohol can cause dangerously low blood sugar (hypoglycemia) and increase the risk of lactic acidosis.
Tell your doctor before taking Glimsentro-PG1 Tablet SR if you have congestive heart failure, kidney or liver problems, or swelling behind your eye. Also inform your doctor if you are pregnant, breastfeeding, or premenopausal, and about all medications you take, including prescription and non-prescription drugs, vitamins, and herbal supplements.
Metformin, a component of Glimsentro-PG1 Tablet SR, can lead to vitamin B12 deficiency with prolonged use due to impaired vitamin B12 absorption in the stomach.
Glimsentro-PG1 Tablet SR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Therefore, regular blood sugar monitoring is crucial. Always keep a readily available sugary snack, such as candy or chocolate, on hand.
Store this medication in its original, tightly closed container, as directed on the packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimsentro-PG1 Tablet SR
122
MRP 149
18% off